GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Psyence Group Inc (XCNQ:PSYG) » Definitions » EV-to-Revenue

Psyence Group (XCNQ:PSYG) EV-to-Revenue : (As of Jun. 03, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Psyence Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Psyence Group's enterprise value is C$25.48 Mil. Psyence Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil. Therefore, Psyence Group's EV-to-Revenue for today is .

The historical rank and industry rank for Psyence Group's EV-to-Revenue or its related term are showing as below:

XCNQ:PSYG's EV-to-Revenue is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.43
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-03), Psyence Group's stock price is C$0.14. Psyence Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00. Therefore, Psyence Group's PS Ratio for today is .


Psyence Group EV-to-Revenue Historical Data

The historical data trend for Psyence Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Group EV-to-Revenue Chart

Psyence Group Annual Data
Trend Dec19 Dec20 Mar22 Mar23 Mar24
EV-to-Revenue
- - - - -

Psyence Group Quarterly Data
Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Psyence Group's EV-to-Revenue

For the Drug Manufacturers - General subindustry, Psyence Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyence Group's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Psyence Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Psyence Group's EV-to-Revenue falls into.


;
;

Psyence Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Psyence Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=25.482/0
=

Psyence Group's current Enterprise Value is C$25.48 Mil.
Psyence Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Group  (XCNQ:PSYG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Psyence Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.14/0
=

Psyence Group's share price for today is C$0.14.
Psyence Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Psyence Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Psyence Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Psyence Group Business Description

Traded in Other Exchanges
Address
121 Richmond Street West, Penthouse Suite, 1300, Toronto, ON, CAN, M5H 2K1
Psyence Group Inc is a life science biotechnology company focused on the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma in the context of palliative care and in support of mental wellness.
Executives
Jody Aufrichtig Director, Senior Officer
Warwick Corden-lloyd Senior Officer
Neil Maresky Senior Officer

Psyence Group Headlines

No Headlines